“益气活血、化瘀散结”中药法对子宫腺肌症高强度聚焦超声消融术后的影响
东莞市南城医院
目的 探析在子宫腺肌症高强度聚焦超声消融术(HIFU)后采用“益气活血、化瘀散结”中药法治疗对患者痛经及病灶清除产生的影响。方法 将医院2024年3月到2025年10月期间诊治的72例子宫腺肌症患者采用随机数表法进行分组,每组36例。对照组实施HIFU治疗,观察组在对照组基础上加用“益气活血、化瘀散结”中药法(四君子汤合桂枝茯苓汤加减)治疗。对比两组治疗前及治疗3个月后视觉模拟评分(VAS)、子宫体积、病灶数量、病灶体积、白细胞(WBC)、红细胞(RBC)、血小板(PLT)、丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)、血清糖类抗原125(CA125)、白细胞介素-6(IL-6)。结果 与对照组相比,观察组治疗后的VAS、子宫体积、病灶数量、病灶体积均较对照组低(P <0.05)。相较于对照组,观察组治疗后的CA125、IL-6水平均较低(P <0.05)。两组治疗后的WBC、RBC、PLT、ALT和AST水平比较未见显著差异(P> 0.05)。结论 在子宫腺肌症HIFU后加用“益气活血、化瘀散结”中药法(四君子汤合桂枝茯苓汤加减)治疗,可进一步缓解痛经,缩小子宫病灶体积,降低病灶活性,且不增加肝功能及血液系统不良反应,具有附加疗效。
Objective To explore the effects of the “Tonifying-qi and activating-blood, resolving-stasis and dissipating-masses” traditional Chinese medicine therapy on dysmenorrhea and lesion clearance after high-intensity focused ultrasound ablation(HIFU) for uterine adenomyosis. Methods The 72 patients with uterine adenomyosis who were treated in the hospital from March 2024 to October 2025 were grouped randomly. Each group consisted of 36 patients. The control group received HIFU treatment, while the observation group received “Tonifying-qi and activatingblood, resolving-stasis and dissipating-masses” traditional Chinese medicine therapy(modified Si Junzi Decoction combined with Guizhi Fuling Decoction). The visual analogue scale(VAS), uterine volume, number of lesions, lesion volume, white blood cells(WBC), red blood cells(RBC), platelets(PLT), alanine aminotransferase(ALT), aspartate aminotransferase(AST), serum carbohydrate antigen 125(CA125), and interleukin-6(IL-6) were compared between the two groups before treatment and 3 months after treatment. Results Compared with the control group, the VAS, uterine volume, number of lesions, and lesion volume of the observation group were lower than those of the control group after treatment(P<0.05). After intervention, the observation group exhibited markedly reduced CA125 and IL-6 concentrations relative to the control cohort, with statistical significance(P<0.05). Meanwhile, post-treatment comparisons of WBC, RBC, PLT, ALT and AST indicators revealed no statistically meaningful disparities between the two groups(P>0.05). Conclusion Adding “Tonifyingqi and activating-blood, resolving-stasis and dissipating-masses” traditional Chinese medicine therapy(modified Si Junzi Decoction combined with Guizhi Fuling Decoction) after HIFU for uterine adenomyosis can further relieve dysmenorrhea, reduce the size of uterine lesions, lower lesion activity, and does not increase adverse reactions in liver function and blood system, and has additional therapeutic effects.
引用本文
按标准格式复制,或导出到文献管理软件参考文献
共 11 条- [1]黄兴华,刘睿倩.子宫腺肌症腹腔镜病灶切除术后GnRH-a联合LNG-IUS治疗效果分析[J].中国妇产科临床杂志,2025,26(5):421-424.
- [2]顾蓉,黄丽,郭彦.米非司酮联合桂枝茯苓汤治疗子宫肌瘤的临床观察[J].安徽医专学报,2025,24(6):100-102.
- [3]中国医师协会妇产科医师分会子宫内膜异位症专业委员会.子宫腺肌病诊治中国专家共识[J].中华妇产科杂志,2020,55(6):376-383.
- [4]郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:332-334.
- [5]唐皓洁,吕喜月,黄玉容,等.《诸病源候论》妇科疾病病因病机及体质思想析要[J].吉林中医药,2023,43(5):510-514.
- [6]陈茜,黄美华,李桢理,等.基于“阳化气,阴成形”论治子宫腺肌症[J].中国现代医生,2026,64(11):88-91.
- [7]耿丹丹,李茂雅,魏绍斌.桂枝茯苓丸治疗子宫腺肌症并不孕症作用机制研究进展[J].辽宁中医杂志,2026,53(2):213-217.
- [8]郭袁梅,刘小菲,沙喜,等.喜棣治疗子宫腺肌症经验探析[J].中医药临床杂志,2025,37(4):630-634.
- [9]陈玲,邱瑜,陈霞.桂枝茯苓汤加减联合针灸对宫腔残留患者宫内组织残留物的清除效果[J].中国医学创新,2023,20(31):19-23.
- [10]曾祯,谢媛,范玉梅.加味桂枝茯苓汤用于子宫内膜异位症并不孕腹腔镜术后临床观察[J].实用中医药杂志,2023,39(3):463-465.
- [11]郭兰珍,周秦,吴淋.加味桂枝茯苓汤辅治卵巢子宫内膜异位症痛经疗效观察[J].实用中医药杂志,2024,40(12):2489-2492.
| 文章编号 | 2026-07-051(期号内编号) |
|---|---|
| 栏目 | 中医学研究 |
| 作者 | 林婷;苏敏琪;周柳群;徐雪琼;王全磊;陈雪梅;杨嘉丽 |
| 作者单位 | 东莞市南城医院 |
| 基金项目 | 广东省中医药局科研课题(20251430) |
| 中图分类号 | R271.9 |
| 卷期页码 | 2026, 2(07): 201-204 |
| 发布时间 | 2026-10-15 |
| 出版时间 | 2026-10-15 |
| 引用信息 | [1]林婷,苏敏琪,周柳群,等.“益气活血、化瘀散结”中药法对子宫腺肌症高强度聚焦超声消融术后的影响[J].疾病预防与控制,2026,2(07):201-204. |
| 全文地址 | 在知网查看该文(kns.cnki.net) |
| 数据抓取时间 | 2026-11-03T03:31:35 |